- Home
- CXAI vs CDIO Comparison
CXAI vs CDIO Comparison
Compare CXAI & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CXAI
- CDIO
- Stock Information
- Founded
- CXAI N/A
- CDIO 2017
- Country
- CXAI United States
- CDIO United States
- Employees
- CXAI N/A
- CDIO N/A
- Industry
- CXAI EDP Services
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CXAI Technology
- CDIO Health Care
- Exchange
- CXAI Nasdaq
- CDIO Nasdaq
- Market Cap
- CXAI 22.4M
- CDIO 19.5M
- IPO Year
- CXAI N/A
- CDIO N/A
- Fundamental
- Price
- CXAI $1.12
- CDIO $4.53
- Analyst Decision
- CXAI
- CDIO Buy
- Analyst Count
- CXAI 0
- CDIO 1
- Target Price
- CXAI N/A
- CDIO $2.00
- AVG Volume (30 Days)
- CXAI 380.1K
- CDIO 68.6K
- Earning Date
- CXAI 05-23-2025
- CDIO 05-23-2025
- Dividend Yield
- CXAI N/A
- CDIO N/A
- EPS Growth
- CXAI N/A
- CDIO N/A
- EPS
- CXAI N/A
- CDIO N/A
- Revenue
- CXAI $7,142,000.00
- CDIO $34,890.00
- Revenue This Year
- CXAI $28.54
- CDIO $1,434.82
- Revenue Next Year
- CXAI $66.67
- CDIO $4,661.91
- P/E Ratio
- CXAI N/A
- CDIO N/A
- Revenue Growth
- CXAI N/A
- CDIO 104.45
- 52 Week Low
- CXAI $0.76
- CDIO $0.19
- 52 Week High
- CXAI $3.82
- CDIO $1.77
- Technical
- Relative Strength Index (RSI)
- CXAI 50.93
- CDIO 29.92
- Support Level
- CXAI $1.04
- CDIO $4.50
- Resistance Level
- CXAI $1.16
- CDIO $14.46
- Average True Range (ATR)
- CXAI 0.06
- CDIO 1.69
- MACD
- CXAI -0.00
- CDIO -0.97
- Stochastic Oscillator
- CXAI 47.06
- CDIO 4.66
About CXAI CXApp Inc.
CXApp Inc is a provider of AI-powered employee experience solutions, delivering enterprise-grade software that enhances workplace engagement, productivity, and operational efficiency. The company's flagship product, the CXAI Platform, provides a comprehensive suite of tools designed to empower employees and enable organizations to create smarter workplaces. The product's key components include CXAI Apps, CXAI BTS, and CXAI-VU. The company generates the majority of its revenue from Licenses.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.